The Valley Hospital swaps in a sharper brain-tumor tool, treating patients without a single incision.

Beam Therapeutics accuses a former scientist of raiding its lab notebooks before co-founding a rival gene-editing startup developing a treatment for a rare disease.

3D printers and new computer labs greet students at Essex County College's newly reopened Newark tech hub.

Zoox is quietly testing snow-ready robotaxi tech in Denver, but human drivers stay behind the wheel for now.

The Alpharetta-founded firm now supports over $400 billion in capital programs, from JFK Airport to Navy bases.

Fleaweight bots duke it out at Sierra College as Maker Faire Rocklin folds in a free preview day and the school's 90th birthday.

Foundation work is underway at 2140 University Avenue, where two lab buildings aim to keep gene-editing startups from decamping to Emeryville.

The San Jose startup wants its chips inside humanoid robots, drones and car dashboards by 2028.

Netlist wants federal regulators to block imports of Micron memory found in Google, Nvidia and Broadcom AI hardware.

TVA is set to become the first utility with an advanced-reactor construction permit, with up to four reactors possible at Clinch River.

Hundreds of CEOs converged on Las Vegas this week to tackle chip, power and grid bottlenecks slowing the AI boom.

Link Cell Therapies began dosing patients with its logic-gated CAR-T therapy at MD Anderson and grew its Series A to $90 million.

A BMJ study found CTE in 215 of 235 donated NFL brains, while its maximum possible prevalence estimate was 97.7% and its conservative minimum across former players was 24.5%.